On Oct 31, major Wall Street analysts update their ratings for $Teladoc Health (TDOC.US)$, with price targets ranging from $9 to $14.
BofA Securities analyst Allen Lutz maintains with a hold rating, and adjusts the target price from $9.5 to $10.5.
Barclays analyst Stephanie Davis maintains with a buy rating, and adjusts the target price from $10 to $12.
Evercore analyst Elizabeth Anderson CFA maintains with a hold rating, and maintains the target price at $9.
Oppenheimer analyst Michael Wiederhorn maintains with a buy rating, and adjusts the target price from $17 to $14.
Needham analyst Ryan MacDonald maintains with a hold rating.
Furthermore, according to the comprehensive report, the opinions of $Teladoc Health (TDOC.US)$'s main analysts recently are as follows:
Teladoc's shares experienced a 12% increase, attributed to a third-quarter performance that surpassed expectations. Analysts suggest seizing the opportunity following the recent adjustments.
The year 2025 is anticipated to be a transitional period, with expectations of relatively stable revenues for IC. Challenges with CAC dynamics are predicted to continue throughout 2025, potentially affecting BH User growth and leading to a decline in revenues compared to the previous year.
Here are the latest investment ratings and price targets for $Teladoc Health (TDOC.US)$ from 9 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
